Zafirlukast is contraindicated for patients with a history of hypersensitivity reaction to the active drug component and the formulation's inactive compounds such as povidone, lactose, titanium dioxide, or cellulose. Zafirlukast is also contraindicated in patients with hepatic impairment and cirrhosis based on case reports of hepatic failure.